Allscripts Closes Previously Announced Sale of CarePort Health Business
Get Alerts MDRX Hot Sheet
Join SI Premium – FREE
CHICAGO--(BUSINESS WIRE)-- On December 31, 2020, Allscripts (NASDAQ: MDRX) closed the previously announced sale of its CarePort Health business to WellSky® Corporation for $1.35 billion. CarePort solutions assist hundreds of hospitals and thousands of post-acute care providers to efficiently coordinate and transition patients through different settings of care.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and The Allscripts Blog.
© 2021 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005126/en/
Investors:
Stephen Shulstein
312-386-6735
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]
Source: Allscripts
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berkshire Hathaway Inc. News Release
- AI Has Made Media Pitching Noisier and Less Effective, Says Featured CEO Brett Farmiloe
- Satish Sanpal Signals Next Phase for ANAX Developments as AED 2 Billion-Plus Pipeline Takes Shape
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share